Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Groundbreaking study in Nature Communications highlights AI's role in transforming immunotherapy decisions and precision oncology IRVING, Texas, Aug. 6, 2025 /PRNewswire/ -- Caris Life Sciences® ...

Revenue surge: Q1 2026 revenue rose 79% to $216.2 million, with gross margins at 65% and positive free cash flow for the fourth straight quarter. Pipeline momentum: Caris advanced products like Caris ...

Perhaps diving headfirst into a New Year’s resolution to put itself out there more, Caris Life Sciences is kicking off 2024 with a pair of new collaborations. Caris—which has built not only a massive ...

Caris Life Sciences issues dividends to shareholders from excess cash Caris Life Sciences generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, annually ...

An Irving-based company on a mission to cure cancer now has deeper pockets to tap for development of its precision medicine technology. Cancer diagnostic research firm Caris Life Sciences said ...

When Caris Life Sciences' new cancer blood test goes fishing for mutations, it casts a wide net—wide enough to capture as many as 22,000 of them, the company says. The company has only presented early ...

IRVING, Texas, Jan. 5, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the ...

IRVING, Texas, Aug. 6, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a new study ...